Nitric oxide in liver injury

Hepatology

Volumn 30, Issue 1, 1999, Pages 1-5

  Clemens, Mark G ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

APOPTOSIS; CELL DAMAGE; CYTOTOXICITY; LIVER BLOOD FLOW; LIVER CELL; LIVER CIRCULATION; LIVER INJURY; LIVER PROTECTION; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

ANIMALS; APOPTOSIS; HUMANS; ISOENZYMES; LIVER; LIVER CIRCULATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 0033027841     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300148     Document Type: Review

References (28)

1. Knowles RG, Merrett M, Salter M, Moncada S. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem J 1990;270:833-836.
2. Esteban FJ, Pedrosa JA, Jimenez A, Fernandez AP, Bentura ML, Martinez-Murillo R, Rodrigo J, et al. Distribution of neuronal nitric oxide synthase in the rat liver. Neurosci Lett 1997;226:99-102.
3. Clemens MG. Does altered regulation of ecNOS in sinusoidal endothelial cells determine increased intrahepatic resistance leading to portal hypertension? HEPATOLOGY 1998;27:1745-1747.
4. Rockey DC, Cluing JJ. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology 1998;114:344-351.
5. Shah V, Haddad FG, Garcia-Cardena G, Frangos JA, Mennone A, Groszmann RJ, Sessa WC. Liver sinusoidal endothelial cells are respon-sible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest 1997;100:2923-2930.
6. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
7. Lautt WW, Greenway CV. Conceptual review of the hepatic vascular bed. HEPATOLOGY 1987;7:952-963.
8. Clemens MG, Bauer M, Pannen BH, Bauer I, Zhang JX. Remodeling of hepatic microvascular responsiveness after ischemia/reperfusion. Shock 1997;8:80-85.
9. Rockey D. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology 1997;25:2-5.
10. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci U S A 1992;89:6711-6715.
11. Rockey DC, Chung JJ. Regulation of inducible nitric oxide synthase in hepatic sinusoidal endothelial cells. Am J Physiol 1996;271:G260-G267.
12. Rockey DC, Chung JJ, McKee CM, Noble PW. Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments. HEPATOLOGY 1998;27:86-92.
13. Curran RD, Billiar TR, Stuehr DJ, Ochoa JB, Harbrecht BG, Flint SG, Simmons RL. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg 1990;212:462-469.
14. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, Nakayamá DK, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A 1993;90:3491-3495.
15. Helyar L, Bundschuh DS, Laskin JD, Laskin DL. Induction of hepatic Ito cell nitric oxide production after acute endotoxemia. HEPATOLOGY 1994;20:1509-1515.
16. Rockey DC, Chung JJ. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility. J Clin Invest 1995;95:1199-1206.
17. Coccheri S, Nazzari M. Defibrotide as a possible anti-ischemic drug. Semin Thromb Hemost 1996;22(Suppl 1):9-14.
18. Ayuse T, Brienza N, Revelly JP, Boitnott JK, Robotham JL. Role of nitric oxide in porcine liver circulation under normal and endotoxemic conditions. J Appl Physiol 1995;78:1319-1329.
19. Mathie RT, Ralevic V, Alexander B, Burnstock G. Nitric oxide is the mediator of ATP-induced dilatation of the rabbit hepatic arterial vascular bed. Br J Pharmacol 1991;103:1602-1606.
20. Pannen BH, Bauer M. Differential regulation of hepatic arterial and portal venous vascular resistance by nitric oxide and carbon monoxide in rats. Life Sci 1998;62:2025-2033.
21. Mittal MK, Gupta TK, Lee FY, Sieber CC, Groszmann RJ. Nitric oxide modulates hepatic vascular tone in normal rat liver. Am J Physiol 1994;267:G416-G422.
22. Zhang JX, Pegoli WJ, Clemens MG. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 1994;266:G624-G632.
23. Shibayama Y, Nakata K. Role of septal fibrosis in development of hepatic circulatory disturbance in the presence of liver cell enlargement. Liver 1992;12:84-89.
24. Harbrecht BG, Billiar TR, Stadler J, Demetris AJ, Ochoa J, Curran RD, Simmons RL. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukoc Biol 1992;52:390-394.
25. Harbrecht BG, Wu B, Watkins SC, Marshall HPJ, Peitzman AB, Billiar TR. Inhibition of nitric oxide synthase during hemorrhagic shock increases hepatic injury. Shock 1995;4:332-337.
26. Saetre T, Gundersen Y, Thiemermann C, Lilleaasen P, Aasen AO. Aminoethyl-isothiourea, a selective inhibitor of inducible nitric oxide synthase activity, improves liver circulation and oxygen metabolism in a porcine model of endotoxemia. Shock 1998;9:109-115.
27. Thiemermann C, Ruetten H, Wu CC, Vane JR. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 1995;116:2845-2851.
28. Wray GM, Millar CG, Hinds CJ, Thiemermann C. Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin. Shock 1998;9:329-335.